Tiziana Life Sciences Ltd

TLSA Nasdaq SEC CIK 1723069
Follow Tiziana Life Sciences Weekly email: filings, results, news

Financials

Reported figures only · latest: Q4 2024 USD · IFRS
EPS, diluted -

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, IFRS
Revenue and net income10 fiscal years
−$30M−$20M−$10M$0FY16FY18FY20FY22FY24
Show the numbers
YearNet income
FY24−$11.9M
FY23−$17.7M
FY22−$15.4M
FY21−$23.4M
FY20−$26.1M
FY19−$9.3M
FY18−$7.9M
FY17−$8.6M
FY16−$9.8M
FY15-
Free cash flowOperating cash flow minus capital expenditure
−$30M−$20M−$10M$0FY16FY18FY20FY22FY24
Show the numbers
YearFree cash flow
FY24−$1.5M
FY23-
FY22-
FY21−$21.8M
FY20−$11.3M
FY19−$6.8M
FY18-
FY17−$7.5M
FY16-
FY15-

News

No stories filed under Tiziana Life Sciences yet - coverage appears here as the news feed clusters it.